Burney Company’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,937
Closed -$241K 588
2024
Q3
$241K Sell
17,937
-643
-3% -$9.48K 0.01% 561
2024
Q2
$257K Sell
18,580
-5,529
-23% -$87.5K 0.01% 536
2024
Q1
$451K Sell
24,109
-2,680
-10% -$53.6K 0.02% 455
2023
Q4
$607K Sell
26,789
-20,782
-44% -$451K 0.03% 396
2023
Q3
$1.18M Sell
47,571
-5,098
-10% -$128K 0.06% 290
2023
Q2
$1.48M Buy
52,669
+684
+1% +$17K 0.07% 271
2023
Q1
$1.16M Buy
51,985
+34,106
+191% +$893K 0.06% 295
2022
Q4
$475K Buy
17,879
+4,923
+38% +$161K 0.02% 411
2022
Q3
$368K Buy
+12,956
New +$333K 0.02% 452

Other funds holding CCRN

Burney Company's CCRN Position: Q4 2024 in Review

Burney Company sold out of Cross Country Healthcare (CCRN) in Q4 2024, closing a stake of 17,937 shares — an estimated $241K sold.

Burney Company first reported a position in CCRN in Q3 2022 and held it in 9 quarters. The position peaked at $1.48M in Q2 2023. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2024.

  • Burney Company reported no remaining Cross Country Healthcare position as of Q4 2024 after selling out during the quarter.
  • Burney Company sold 17,937 Cross Country Healthcare shares in Q4 2024, an estimated $241K.
  • Burney Company first reported a position in Cross Country Healthcare in Q3 2022 and held it in 9 quarters.
  • Burney Company's Cross Country Healthcare position peaked at $1.48M in Q2 2023.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2024.

Based on Burney Company's 13F filing for Q4 2024, filed 14 Jan 2025.